Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-07-19 to 2023-08-07
Current total value of award: $12485
Description: 4561540503!ATEZOLIZMAB 60MG/ML 1S